Oxymap
PrivateTotal Funding Raised
$386,000
Company Overview
Oxymap is a medical technology company that develops and markets non-invasive retinal oximetry devices and software for eye-care professionals and clinical researchers.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxymap Comparables
Compare Oxymap with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zilia | 83% | |
| Imedos Systems GmbH | 80% | |
| RetinaLyze System A/S | 71% |
Oxymap Funding Rounds
Historical fundraising activity
Oxymap Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rannís - The Icelandic Centre for Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Web traffic grew 83% MoM (from 844 to 1.5K monthly visitors)
- Jul 3, 2025
Monthly visitors increased 125% MoM, reaching 304.
Oxymap Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Oxymap's valuation, stock price, and market status.
Is Oxymap a public or private company?
Oxymap is a private company.
What is the current stock price of Oxymap?
Oxymap is a private company with no public stock price. Caplight tracks Oxymap's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Oxymap worth (valuation)?
Valuation information for Oxymap is not publicly available.
Can I buy Oxymap stock?
Oxymap shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Oxymap's last funding round?
Funding round information for Oxymap is not publicly available.
Who are the main investors in Oxymap?
Key investors in Oxymap include Rannís - The Icelandic Centre for Research.
Will Oxymap IPO soon?
No public IPO plans have been announced for Oxymap.
How can I track Oxymap secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oxymap's secondary market activity and sign up for updates.